海南椰島(600238.SH):海南紅棉已通過集中競價減持448.2萬股
格隆匯 4 月 30日丨海南椰島(600238.SH)公佈,公司於2021年4月30日收到海南紅棉投資有限公司(“海南紅棉”)發來的《關於減持海南椰島股份的吿知函》。函稱截止2021年4月30日,海南紅棉通過集中競價交易方式減持公司股份448.2萬股股票,佔公司總股份的1%,減持後持有公司股份1412.2055萬股,佔公司總股份的3.15%。
此次權益變動後,王貴海通過受託北京東方君盛投資管理有限公司表決權及其控制的海南紅棉投資有限公司與一致行動人田高翔合計持有的公司股份表決權110,973,879股,佔公司總股本的24.76%,不會導致公司實際控制人發生變化,王貴海仍為公司實際控制人。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.